Evan A. Stein, M.D., Ph.D., of the Metabolic and Atherosclerosis Research Center in Cincinnati and the only U.S. ENHANCE investigator, defended the use of ezetimibe.
Taking the opposing view is Allen J. Taylor, M.D., of the Uniformed Services University of the Health Sciences Walter Reed Army Medical Center in Washington and co-author of a New England Journal of Medicine editorial on the ENHANCE trial.
Drs. Taylor and Stein were interviewed separately at the MedPage Today offices in Little Falls, N.J., on April 9 and 10 by Peggy Peck, Executive Editor, MedPage Today.
The physicians received no honoraria from MedPage Today. They were reimbursed for travel expenses.
No comments:
Post a Comment